SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUIs sharp rebound is drawing attention, with traders framing the move as part of a broader altcoin rally and watching for a breakout to extend gains. Bullish calls are prominent, though some remain cautious after recent volatility and question whether the momentum can hold.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks upcoming Phase 3 DAYBREAK topline results for Zenkuda and KSI-501 in wet AMD are driving attention, with the readout scheduled for September 28. Traders are split on the drugs chances of success and are weighing potential upside against the risk and volatility of holding through a binary catalyst.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solanas rebound and push through a closely watched resistance area are driving discussion, with bullish traders pointing to the broader crypto and altcoin rally and growing interest in Solanas tokenization ecosystem. Others see the move as vulnerable to a pullback, citing resistance, fading momentum, and Bitcoins direction.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

FETs recent rebound and strength versus other crypto assets have traders watching for a breakout, with many attributing interest to renewed demand for AI tokens and Fetch.ais autonomous-agent ecosystem. Bullish posts see room for further gains, while skeptics call the move temporary and point to resistance levels and Bitcoins direction as risks.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais expanded, multiyear cloud agreement with Anthropic to support AI computing workloads is driving attention, with traders weighing the growth opportunity against the upfront capital spending, potential dilution, and delayed revenue ramp. The sharp initial rally gave way to a steep fade, prompting a sell-the-news debate: some see a transformative AI-infrastructure deal, while others question its near-term economics.

Polygon

POL is drawing attention for its persistent underperformance versus other cryptocurrencies and difficulty holding rallies, with traders pointing to selling pressure and dilution concerns. Bulls counter that Polygons growing payments and stablecoin use, integrations, and network upgrades support its longer-term potential.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charters sharp selloff is being tied to its latest results and persistent broadband subscriber losses, with traders also concerned about heavy debt, paused buybacks, and the dilution and costs associated with the Cox deal. Bulls argue the depressed valuation and cash flow offer value, while bears see continued customer losses as a threat; SpaceX partnership speculation remains unconfirmed.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistras persistent share-price weakness is driving debate over its financing filings: some traders fear dilution from a possible stock sale, while others note that the disclosed $1.5 billion notes offering is debt and a shelf registration alone does not confirm an equity issuance. Bulls continue to point to AI and data-center power demand, but many are frustrated that the long-term thesis has not translated into stronger price action.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

EyePoints DURAVYU missing the primary endpoint in its LUGANO Phase 3 trial has drawn attention to Oculars AXPAXLI, with traders viewing the result as easing competitive pressure and strengthening Oculars position in wet AMD. The community remains divided over whether AXPAXLIs trial results will translate into meaningful market adoption, alongside speculation about a potential buyout.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

Strength in semiconductor and AI-related shares is weighing on SOXS, the leveraged inverse semiconductor ETF, as traders debate whether the chip rally can continue or is due for a pullback. Bears cite stretched valuations and macro risks, while others point to strong sector momentum and warn that leverage and decay can magnify losses when the trend runs against them.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The move appears tied to volatile low-float momentum and short-squeeze speculation. Traders are also focusing on reported debt-for-equity exchanges that converted about $6.7 million of debt into shares, a transaction that may reduce debt while adding dilution concerns.

Catalysts Remain in Focus as Investors Hunt Next Big Move

The market is serving up a similar mix of names as Jaguar Health (NASDAQ:JAGX), NeOnc Technologies Holdings (NASDAQ:NTHI), Greenland Mines (NASDAQ:GRML), Beneficient (NASDAQ:BENF) and Apimeds Pharmaceuticals (NYSEAMERICAN:APUS) all had major catalysts this week, while INLIF LIMITED (NASDAQ:INLF) is the only new name to today’s list.

Jaguar Health Stock Surges Friday: What's Happening?

Jaguar Health is surging Friday after announcing debt-for-equity exchanges that cut debt by over $6.7 million and retired a promissory note.read more...

Jaguar Health Stock Slides Thursday: What's Happening?

Jaguar Health shares are sliding Thursday as equity dilution concerns weigh on the company following a debt-for-equity exchange.read more...

Jaguar Health Stock Plunges Wednesday: What's Happening?

Jaguar Health shares are plunging Wednesday morning as profit-taking reverses an explosive Tuesday rally sparked by regulatory fee waivers.read more...

InnovAge, Voyager Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. futures edged higher; InnovAge fell 9.4% after a 10M-share offering. Jaguar Health, Voyager Technologies and other stocks also dropped premarket.read more...

Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

Worthington Enterprises surged 15.9% premarket after beating Q1 EPS and sales estimates; Wheeler REIT led gainers, while Jaguar Health and Biomea fell.read more...

JAGX Stock Soars Over 10% Premarket After Best Day In Over 8 Years: What’s Driving The Surge?

Equity

Jaguar Health aims to file for approval of its Crofelemer powder treatment for pediatric MVID in mid-2027.

Jaguar Health Stock Surged 1200% on Tuesday: Here's Why JAGX Stock Is Trending After Hours

Jaguar Health shares jumped 5.19% after hours following FDA fee waivers for two of its commercialized therapies.read more...

Jaguar Health, IONQ, Viking Therapeutics, Xanadu Quantum and Grab Holdings: Why These 5 Stocks Are on Investors' Radars Today

JAGX, IONQ, VKTX, XNDU, GRAB were among the stocks seen trending on Tuesday, Sept. 22, 2026.read more...

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

Jaguar Health (NASDAQ:JAGX) shares moved upwards by 32.2% to $45.56 during Tuesday's after-market session. The company's market cap stands at $1.1 million.
Bullfrog AI Hldgs (NASDAQ:BFRG) sharesread more...

This account has been verified as an official JAGX representative.

Verified Account

Jagaur Health

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the following segments: Animal Health and Human Health. The Animal Health segment is focused on development and commercialization of prescription and non-prescription products for companion and production animals. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Jaguar Health Inc

Extremely Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

JAGX Jaguar Health Inc